HomeOwner SearchCategory Search
Visit USCOImproving Titer and Infectivity of Lentiviral Vectors for Gene and Cell Therapy
Text Registration
Copyright Title
Improving Titer and Infectivity of Lentiviral Vectors for Gene and Cell Therapy
Status
Published
on 2 Jul 2021
Year of Creation
2021
Copyright Claimant
Jiaying Han
Registration Number
TX0008998647
on 2 Jul 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008998647) dated 2 Jul 2021, pertains to an electronic file (eService) titled "Improving Titer and Infectivity of Lentiviral Vectors for Gene and Cell Therapy" created in 2021. The copyright holder is Jiaying Han, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Jiaying Han.
Application Details
Registration Number
TX0008998647
Registration Date
7/2/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Improving Titer and Infectivity of Lentiviral Vectors for Gene and Cell Therapy
Author Statement: Jiaying Han Citizenship: not known Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.